BORR vs HLX

BORR's Piotroski F-Score of 4/9 indicates borderline financial health, while the absence of an Altman Z-Score prevents a full distress risk assessment. The stock trades below its Graham Number of $5.01 at $4.47, suggesting modest undervaluation, though forward P/E of -47.51 signals expected earnings deterioration. Strong operating and gross margins contrast with high debt/equity of 1.80 and inconsistent earnings growth, particularly the recent Q/Q EPS decline of -35.7%. Technical trend is weak at 10/100, but dividend strength and insider sentiment are below average, contributing to a cautious outlook.

HLX presents a stark disconnect between market price and fundamental value, evidenced by a Piotroski F-Score of 4/9 (Stable) and a Graham Number of $4.91, which is roughly half the current trading price. While the balance sheet is healthy with low debt and strong liquidity, the company is suffering from a catastrophic earnings collapse (-550% YoY EPS growth) and negative operating margins. The current P/E of 99.30 is unsustainable, and the stock's valuation relies entirely on optimistic forward estimates (Forward P/E 17.81) that are not yet supported by realized growth. With a technical trend score of 10/100 and bearish insider activity, the current price appears to be driven by momentum rather than intrinsic value.